Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Ercros, S.A. is a century-old Spanish industrial group specializing in the manufacture and sale of chemical and pharmaceutical products. As Spain's first basic chemicals company, it leads in most markets it serves, operating through three diversified divisions: Chlorine derivatives, linking various products with chlorine; Intermediate chemicals, centered on formaldehyde chemistry; and Pharmaceuticals, producing active pharmaceutical ingredients. With 10 production sites across Spain, it employs approximately 1,335 people and exports 54% of its sales—valued at 643 million euros in 2024—to around 100 countries, serving major clients like BASF, Bayer, and Henkel. Headquartered in Barcelona, Ercros prioritizes safety, environmental respect, product quality, and transparency, earning accolades such as UN Global Compact recognition, EcoVadis ESG rating of 87/100, and sustainability awards. Its products contribute to everyday essentials, from water treatment and plastics to electronics and medications, underscoring its role in advancing chemical solutions for societal well-being and sustainability.
€3.46
+€0.00 (+0.00%)
EOD Jun 23, 2026 · Twelve Data
The business is unprofitable at the operating level (-4.41% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 6.2% YoY. Margins deteriorated 4.0pp alongside, both lines moving the wrong way.
ROIC dropped from -0.44% to -4.10%, capital efficiency is deteriorating. Operating margin contracted 4.0pp YoY, cost discipline may be slipping.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€575M
▼ -6.2% YoY
Net Income (TTM)
-€55M
▼ -359.7% YoY
Op. Margin
-4.95%
▼ -4.0pp YoY
ROIC
-4.10%
▼ -3.7pp YoY
Cash Flow & Balance Sheet
FCF (FY)
€38M
▲ +1049.7% YoY
Op. Cash Flow (FY)
€49M
▲ +417.0% YoY
Net Debt
€129M
Cash & Equiv.
€94M
3Y CAGR: -15.5%
3Y CAGR: -11.7%
Continue Research